Reuters logo
BRIEF-Catalyst Biosciences’ Factor IX recommended for orphan drug designation in Europe
2017年5月31日 / 中午12点28分 / 6 个月前

BRIEF-Catalyst Biosciences’ Factor IX recommended for orphan drug designation in Europe

May 31 (Reuters) - Catalyst Biosciences Inc

* Catalyst Biosciences’ Factor IX recommended for orphan drug designation in europe

* Catalyst Biosciences -isu abxis, plans to initiate phase 1/2 proof-of-concept study of cb 2679d in individuals with severe hemophilia b in june in south korea Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below